WO2023078465A1 - 耗材管理系统、管理方法及血管钙化治疗设备 - Google Patents

耗材管理系统、管理方法及血管钙化治疗设备 Download PDF

Info

Publication number
WO2023078465A1
WO2023078465A1 PCT/CN2022/130739 CN2022130739W WO2023078465A1 WO 2023078465 A1 WO2023078465 A1 WO 2023078465A1 CN 2022130739 W CN2022130739 W CN 2022130739W WO 2023078465 A1 WO2023078465 A1 WO 2023078465A1
Authority
WO
WIPO (PCT)
Prior art keywords
module
signal
power
consumable
fuse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2022/130739
Other languages
English (en)
French (fr)
Inventor
唐智皇
李闯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Pnp Medtech Co Ltd
Original Assignee
Jiangsu Pnp Medtech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Pnp Medtech Co Ltd filed Critical Jiangsu Pnp Medtech Co Ltd
Priority to EP22889486.1A priority Critical patent/EP4397256A4/en
Priority to JP2024526756A priority patent/JP7652475B2/ja
Priority to US18/703,373 priority patent/US20250235225A1/en
Publication of WO2023078465A1 publication Critical patent/WO2023078465A1/zh
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/32—Surgical cutting instruments
    • A61B17/320068—Surgical cutting instruments using mechanical vibrations, e.g. ultrasonic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22004—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
    • A61B17/22012—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
    • A61B17/22022—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement using electric discharge
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/08—Accessories or related features not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00017—Electrical control of surgical instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/22004—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
    • A61B17/22012—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
    • A61B2017/22025—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement applying a shock wave
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • A61B2017/22062—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation to be filled with liquid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/08—Accessories or related features not otherwise provided for
    • A61B2090/0803—Counting the number of times an instrument is used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/08—Accessories or related features not otherwise provided for
    • A61B2090/0814—Preventing re-use

Definitions

  • the present application relates to the technical field of medical devices, in particular to a consumable management system, a management method and a vascular calcification treatment device.
  • Vascular stenosis refers to the pathological process in which hydroxyapatite minerals are deposited in the vascular system.
  • Human arteriovenous, coronary, peripheral, intracranial and other blood vessels are due to abnormal lipid metabolism, and the lipids in the blood are deposited in the originally smooth blood vessels.
  • the intima gradually accumulates into atherosclerotic lipid plaques.
  • lipid plaques increase and calcification causes narrowing of the vessel lumen, obstructing blood flow, leading to ischemia in downstream vessels and the body, and corresponding clinical manifestations .
  • 30% to 50% of vascular stenosis will have calcified plaques, and both coronary arteries and peripheral arteries may have calcified lesions, which is extremely difficult to treat.
  • a shock wave therapy device consisting of a generator, a catheter, and a consumable balloon (a consumable electrode is arranged in the balloon), that is, a calcification therapy device.
  • the balloon is placed in the lesion through the guide wire, and then the calcification is broken up by ultrasonic technology to achieve the purpose of treatment.
  • Generators and catheters can be used for patient treatment multiple times in a row, but the balloon is used as a disposable medical consumable, and the consumable balloon is in direct contact with the human body, so the safety of the consumable is also extremely important.
  • this application provides a consumable end management system, management method and vascular calcification treatment equipment, which can distinguish and identify the disposable consumable end, so that it can effectively avoid the secondary use of consumables, thereby avoiding the secondary use that may cause security risks, high stability and low cost.
  • the consumable terminal management system includes: a control circuit and a consumable circuit, and the control circuit includes a processing module and a first power supply module And the second power supply module, the consumable circuit includes a fuse module, the consumable circuit is arranged at the consumable end, wherein,
  • the processing module is configured to output a detection trigger signal to the first power module, and output a fuse trigger signal to the second power module when it is determined that the state of the fuse module is on;
  • the first power supply module is configured to receive the detection trigger signal, and output a first power supply signal to the fuse module for state detection of the fuse module;
  • the second power supply module is used for receiving the fusing trigger signal, and outputting a second power supply signal to the fusing module, so as to keep the fusing module in a disconnected state.
  • the processing module outputs the fusing trigger signal to the second power supply module to control the second power supply when it determines that the state of the fusing module is on and triggers pulse therapy.
  • the module outputs a second power signal to the fuse module for making the fuse module in a disconnected state.
  • the fuse module includes a fuse and a resistor, the first end of the fuse is used to receive the first power signal or the second power signal, and the second end of the fuse to ground through said resistor;
  • the processing module is connected to the second end of the fuse, and is used to obtain a monitoring signal, so as to judge the state of the fuse module according to the monitoring signal.
  • the first power module includes a first switch and a voltage source
  • the second power module includes a second switch and a current source
  • the first switch When the first switch receives the detection trigger signal, it turns on the voltage source and the fuse module, so that the voltage source outputs the first power signal to the fuse module;
  • the second switch turns on the current source and the fuse module when receiving the fuse trigger signal, so that the current source outputs the second power signal to the fuse module.
  • control circuit further includes a third power module
  • consumable circuit further includes a connection module
  • connection module connects the third power module and the processing module through a feedback signal line
  • the processing module When the processing module receives a feedback signal corresponding to the third power signal output by the third power module through the connection module, it outputs a detection trigger signal to the first power module.
  • the present invention provides a consumable end management method.
  • the method includes:
  • the step of outputting the detection trigger signal to the first power module so that the first power module outputs the first power signal to the fuse module in the consumable end includes:
  • the detection trigger signal is output to the first power module, so that the first power supply
  • the module outputs the first power signal to the fuse module in the consumable end.
  • the fuse trigger signal when it is determined that the state of the fuse module is on, the fuse trigger signal is output to the second power module, so that the second power module outputs a second power signal to the fuse module, so that the step of fusing the fusing module according to the second power supply signal includes:
  • a fusing trigger signal is output to the second power supply module, so that the second power supply module outputs a second power supply signal to the fusing module, so that the fusing module The signal is fused.
  • the fuse trigger signal is output to the second power module, so that the second power module outputs a second power signal to the fuse module, thereby After the step of making the fuse module fuse according to the second power signal, it includes:
  • the present invention also provides a vascular calcification treatment device.
  • the vascular calcification treatment device includes a device end, a connector, and the consumable end described in any of the above-mentioned embodiments.
  • the terminal is connected to the consumable terminal through the connector, the consumable terminal also includes a consumable electrode, and the device terminal includes a main power module, a step-down circuit, a boost circuit, and the control circuit described in any one of the above-mentioned embodiments; in,
  • the main power supply module is connected to the boost circuit, and is connected to the processing module, the first power supply module and the second power supply module through the step-down circuit to supply power;
  • the processing module is connected to the boost circuit, and is used to control the boost circuit to output a pulse signal;
  • the voltage boosting circuit is connected to the electrodes of the consumables to form a high-voltage discharge circuit to release the pulse signal.
  • the consumable end management system includes a control circuit and a consumable circuit
  • the control circuit includes a processing module, a first power module, and a second power module
  • the consumable circuit includes a fuse module
  • the consumable circuit is set at the consumable end
  • the processing module is used to output the detection trigger signal to the first power module, and when it is determined that the state of the fuse module is in the conduction state, output the fuse trigger signal to the second power module
  • the first power module is used to receive the detection trigger signal, and Outputting the first power signal to the fuse module for state detection of the fuse module
  • the second power module is used to receive the fuse trigger signal and output the second power signal to the fuse module to make the fuse module in the disconnected state.
  • the invention can distinguish and identify the ends of the disposable consumables, thereby effectively avoiding the secondary use of the consumables, further avoiding possible safety risks caused by the secondary use, and has high stability and low cost.
  • the consumable end management method and the vascular calcification treatment device provided by the present invention belong to the same inventive concept as the consumable end management system provided by the present invention, and thus have the same beneficial effects.
  • Fig. 1 is a structural block diagram of an existing vascular calcification treatment device.
  • Fig. 2 is a schematic structural diagram of a consumable end management system provided by an embodiment of the present invention.
  • Fig. 3 is a schematic structural diagram of a fuse module provided by an embodiment of the present invention.
  • Fig. 4 is a schematic diagram of the specific structure and connection of the first power module and the second power module provided by an embodiment of the present invention.
  • Fig. 5 is a schematic structural diagram of a consumable end management system provided by another embodiment of the present invention.
  • FIG. 6 is a schematic flowchart of a method for managing consumables provided by an embodiment of the present invention.
  • Fig. 7 is a schematic structural diagram of a device for treating vascular calcification according to an embodiment of the present invention.
  • Fig. 8 is a schematic diagram of the workflow of the vascular calcification treatment device provided by an embodiment of the present invention.
  • FIG. 1 is a structural block diagram of an existing vascular calcification treatment device.
  • the existing vascular calcification treatment device includes a device end 10 , a consumable end 20 and a connector 30 , and the device end 10 is connected to the consumable end 20 through the connector 30 .
  • the consumable end is delivered to the vascular site to be treated through the guide wire through 20, and the high-voltage pulse generated by the device end 10 is sent to the electrode of the consumable end 20 through the connector 30, and shock waves are generated by the consumable electrode to fragment the calcified tissue.
  • the consumable ends cannot be distinguished and identified, and the problem of reusable consumable ends will arise.
  • the consumable end management system provided by this application can be set on such equipment for consumable end management, distinguish and identify disposable consumable ends, effectively avoid the secondary use of consumables, thereby avoiding possible safety risks caused by secondary use, and is stable High reliability and low cost.
  • FIG. 2 is a schematic structural diagram of a consumable end management system provided by an embodiment of the present invention.
  • the consumable end management system includes: a control circuit 100 and a consumable circuit 200 , the control circuit 100 includes a processing module 110 , a first power module 120 and a second power module 130 , the consumable circuit 200 includes a fuse module 210 , and the consumable circuit 200 is set at the end of consumables, wherein,
  • the processing module 110 is configured to output a detection trigger signal to the first power module 120, and output a fuse trigger signal to the second power module 130 when it is determined that the state of the fuse module 210 is in a conduction state;
  • the first power supply module 120 is used for receiving the detection trigger signal, and outputting the first power supply signal to the fuse module 210 for state detection of the fuse module 210;
  • the second power supply module 130 is used for receiving the fusing trigger signal, and outputting the second power supply signal to the fusing module 210, so as to make the fusing module 210 in a disconnected state.
  • control circuit 100 and the consumable circuit 200 can be connected through a connector, the fuse module 210 is arranged at the consumable end, the processing module 110, the first power module 120 and the second power module 130 can be arranged at the device end, and the processing module 110 can be microcontroller.
  • the control circuit 100 is connected to the consumables circuit 200, and the consumables at the consumables end are connected to the corresponding device at the device end (for example, the consumables electrode at the consumables end in the vascular calcification treatment equipment is connected to the output end of the booster circuit at the device end.
  • the processing module 110 outputs the detection trigger signal to the first power supply module 120, and the first power supply module 120 outputs the first power supply signal to the fuse module 210 after receiving the detection trigger signal, so as to be used for the state detection of the fuse module 210, that is, to judge Whether the fusing module 210 is in a fusing state.
  • the processing module 110 determines that the state of the fusing module 210 is in the on state, that is, when no fusing has occurred, that is, the consumable end is a new consumable end, the processing module 110 then outputs a fusing trigger signal to the second power supply module 130, the second The second power supply module 130 outputs a second power supply signal to the fuse module 210 after receiving the fuse trigger signal, so as to keep the fuse module 210 in a disconnected state, even if the fuse module 210 is blown.
  • the processing module 110 determines that the state of the fuse module 210 is disconnected after the consumable terminal is connected and has not yet performed fusing processing, that is, when fusing has occurred, the consumable is determined to be an old consumable, and there is no need to send a fusing trigger signal.
  • the processing module 110 determines the state of the fuse module 210, the processing module 110 stops outputting the detection trigger signal.
  • the processing module 110 controls the second power supply module 130 to output a second power signal to the fuse module 210 when determining that the state of the fuse module 210 is on and triggers pulse therapy, so as to make the fuse module 210 in the Disconnected state.
  • the consumable end is connected to the device end, but The device end does not send high-voltage pulses to the consumable electrode of the consumable end, that is, the consumable end has not been used for treatment, but the consumable end is misjudged as an old consumable and the fuse module 210 is fused.
  • the processing When the module 110 determines that the state of the fuse module 210 is on and triggers the pulse treatment (that is, when the processing module 110 detects that the over-pulse treatment is triggered, or detects that the over-pulse treatment signal is sent), it outputs a fuse trigger signal to the second power supply module, to control the second power supply module 130 to output a second power supply signal to the fuse module 210, so as to make the fuse module 210 in an off state.
  • the processing module 110 outputs the fusing trigger signal to the second power module 130, so that the second power module 130 outputs the second power signal to the fusing module 210, for making the fusing module 210 in the disconnected state , and output the detection trigger signal to the first power module 120 again, so that the first power module 120 outputs the first power signal to the fuse module 210 for judging whether the fuse module 210 is in the disconnected state.
  • FIG. 3 is a schematic structural diagram of a fuse module provided by an embodiment of the present invention.
  • the fuse module 210 includes a fuse FU and a resistor R, the first end of the fuse FU is used to receive the first power signal or the second power signal, and the second end of the fuse FU Connect to ground through resistor R.
  • the processing module 110 is connected to the second end of the fuse FU for acquiring a monitoring signal for judging the state of the fuse module 210 .
  • the first power signal when the first power signal is output to the fuse module 210, if the end of the consumable is a new end of the consumable, the first power signal passes through the fuse FU and the resistor R to the power ground, and the voltage signal amplitude of the first power signal is Low, the current flowing through the fuse FU cannot blow the fuse FU.
  • the monitoring signal obtained by the processing module 110 is at a high level, and the processing module 110 considers it to be a new consumable after detecting the high level signal. If the end of the consumable is a used end, the fuse FU in the fuse module 210 has been blown, and the current cannot flow through the fuse FU. At this time, the monitoring signal obtained by the processing module 110 is at a low level. Therefore, the usage status of the consumable end can be distinguished by monitoring the difference between the high and low levels of the signal.
  • the processing module 110 after the detection of the consumable end is completed, the processing module 110 no longer detects the monitoring signal, and at the same time, the processing module 110 controls the first power module 120 to stop outputting.
  • FIG. 4 is a schematic diagram of the specific structure and connection of the first power module and the second power module provided by an embodiment of the present invention.
  • the first power module 120 includes a first switch K1 and a voltage source Us
  • the second power module 130 includes a second switch K2 and a current source Is.
  • the first switch K1 turns on the voltage source Us and the fuse module 210 when receiving the detection trigger signal, so that the voltage source Us outputs the first power signal to the fuse module 210 .
  • the second switch K2 receives the fusing trigger signal, it turns on the current source Is and the fusing module 210 , so that the current source Is outputs the second power signal to the fusing module 210 .
  • FIG. 5 is a schematic structural diagram of a consumable end management system provided by another embodiment of the present invention.
  • the control circuit 100 further includes a third power module 140
  • the consumable circuit 200 further includes a connection module 220 for connecting the third power module 140 and the processing module 110 .
  • the processing module 110 outputs a detection trigger signal to the first power module 120 when receiving a feedback signal corresponding to the third power signal output by the third power module 140 through the connection module 220 .
  • connection module 220 may include a wire for connecting the output terminal of the third power supply module 140 and the feedback signal pin of the processing module 110, and the connection module 220 provided at the end of the consumables is connected to the third power supply module 140 and the processing module 110, the pins of the processing module 110 receive a feedback signal corresponding to the third power signal output by the third power module 140, and the processing module 110 judges that the consumable end has been connected to the device end according to the feedback signal. For example, when the consumable end is not connected, the feedback signal is a low-level signal, and after the consumable end is connected, the feedback signal will be a high-level signal. Similarly, after the consumable end is disconnected from the device end, the feedback signal pin will become low level. After judging that the consumable end is connected, the device side starts to detect the state of the fuse module 210 in the consumable end, and distinguishes whether the connected consumable end is a new end or a used end.
  • the processing module 110 is further configured to decrement the number of remaining treatments at the consumable end according to the pulse treatment control signal.
  • the processing module 110 outputs a fusing trigger signal to the second power module, so as to control the fusing module 210 to set the remaining number of treatments to the effective maximum value after it is confirmed that the fusing module 210 is effectively fusing.
  • the device can perform pulse therapy according to the displayed remaining therapy times. With each pulse therapy performed by the user, that is, when the processing module 110 receives the pulse therapy control signal, the remaining number of treatments is reduced by one until the number of remaining treatments is reduced to zero.
  • control circuit 100 further includes a backup power supply for powering the processing module 110 when the processing module 110 is in a low power consumption state.
  • the processing module 110 triggers a low power consumption state, and the backup battery supplies power to the processing module 110.
  • the processing module 110 is not completely powered off, and the remaining treatment times at the consumable end can still be memorized. , so that when the consumable end is used again, the processing module 110 can continue to perform pulse therapy according to the remaining number of treatments.
  • control circuit 100 further includes an alarm module, and the processing module 110 is connected to the alarm module, and is used to control the alarm module to give an alarm prompt when the remaining number of treatments at the consumable end is 0.
  • the alarm module can be a buzzer and/or an LED light, etc.
  • the consumable end management system provided by the embodiment of the present invention can distinguish and identify the disposable consumable end, so as to effectively avoid the secondary use of consumables, thereby avoiding the possible safety risks caused by the secondary use, and can also identify the disposable consumables. Effective security management and control for the use of terminals, with high stability and low cost.
  • FIG. 6 is a schematic flowchart of a consumable end management method provided by an embodiment of the present invention. As shown in Figure 6, the methods include:
  • step S10 outputting the detection trigger signal to the first power module, so that the first power module outputs the first power signal to the fuse module in the consumable end, includes:
  • a detection trigger signal is output to the first power module, so that the first power module outputs the first power signal to the fuse in the consumable terminal module.
  • the state of the fuse module includes an on state and an off state
  • the on state represents that the consumable end is a new consumable
  • the off state represents that the consumable end is a used consumable
  • step S30 when it is determined that the state of the fuse module is on, outputs a fuse trigger signal to the second power module, so that the second power module outputs a second power signal to the fuse module, so that the fuse module Fusing according to the second power signal, including:
  • the pulse therapy control signal is monitored
  • a fusing trigger signal is output to the second power module, so that the second power module outputs a second power signal to the fusing module, so that the fusing module performs fusing according to the second power signal.
  • the fusing trigger signal is output to the second power supply module, so that the second power supply module outputs the second power supply signal to the fusing module, so that the fusing module performs the treatment according to the second power supply signal.
  • the remaining number of treatments at the consumable end is set to the effective maximum value
  • pulse therapy When the remaining number of treatments on the consumable end is greater than 0, pulse therapy will be triggered and the remaining number of treatments on the consumable end will be decremented;
  • the remaining number of treatments on the consumable end is set to the effective maximum value, which means subtracting 1 from the default maximum value on the consumable end.
  • the consumable end management method further includes:
  • the pulse therapy control signal is monitored
  • pulse therapy When the remaining number of treatments on the consumable end is greater than 0, pulse therapy will be triggered and the remaining number of treatments on the consumable end will be decremented;
  • the consumable end management method provided by the embodiment of the present invention can distinguish and identify the disposable consumable end, effectively avoid the secondary use of the consumable, thereby avoiding the safety risk that may be caused by the secondary use, and can also effectively control the use of the consumable end. Security control, high stability and low cost.
  • FIG. 7 is a schematic structural diagram of a device for treating vascular calcification according to an embodiment of the present invention.
  • the device includes: a device end 10a, a consumable end 20a, and a connector 30a, the device end is connected to the consumable end through the connector, and the consumable end 20a includes a consumable electrode 230 and the consumable circuit described in any of the above-mentioned embodiments 200.
  • the device end 10a includes a main power supply module 150, a step-down circuit 160, a boost circuit 170, and the control circuit 100 of any of the above-mentioned embodiments; wherein,
  • the main power supply module 150 is connected to the boost circuit 170, and is connected to the processing module 110, the first power supply module 120 and the second power supply module 130 through the step-down circuit 160 to supply power;
  • the processing module 110 is connected to the boost circuit 170, and is used to control the boost circuit 170 to output a pulse signal;
  • the boost circuit 170 is connected with the consumable electrode 230 to form a high voltage discharge circuit to release the pulse signal.
  • the main power module 150 is connected to the third power module 140 through the step-down circuit 160 to provide power.
  • FIG. 8 is a schematic workflow diagram of a device for treating vascular calcification according to an embodiment of the present invention.
  • the workflow of the vascular calcification treatment device includes the following steps:
  • S110 The device side monitors whether the feedback signal is at a high level
  • step S111 the device end outputs the first power signal to the consumable end, and receives the monitoring signal;
  • step S113 When judging that the consumable end is a new consumable, enter step S113: whether the device end receives a pulse therapy control signal;
  • step S113 when the device end does not receive the pulse therapy control signal
  • step S114 the device end outputs a second power signal to the consumable end, so that the consumable end is fused.
  • Step S115 Detect whether the consumable end is effectively blown
  • step S116 the equipment end sets the remaining number of treatments at the consumable end to the effective maximum value
  • Step S117 judging whether a pulse therapy control signal is received
  • step S118 determine whether the remaining number of treatments at the consumable end is greater than 0;
  • step S119 trigger pulse therapy, and subtract 1 from the remaining treatment times at the consumable end;
  • step S120 do not trigger pulse therapy, and send an alarm prompt that the life cycle is over.
  • the vascular calcification treatment device provided by the embodiment of the present invention can distinguish and identify the end of the disposable consumable, so it can effectively avoid the secondary use of the consumable, thereby avoiding the safety risk that may be caused by the secondary use, and can also identify the end of the consumable. Use for effective security control, high stability and low cost.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pathology (AREA)
  • Dentistry (AREA)
  • Surgical Instruments (AREA)
  • Electrotherapy Devices (AREA)

Abstract

一种耗材端管理系统、管理方法及血管钙化治疗设备，其中，耗材端管理系统包括：控制电路（100）和耗材电路（200），控制电路（100）包括处理模块（110）、第一电源模块（120）以及第二电源模块（130），耗材电路（200）包括熔断模块（210），耗材电路（200）设置于耗材端（20），处理模块（110）用于输出检测触发信号至第一电源模块（120），并在判定熔断模块（210）的状态为导通状态时，输出熔断触发信号至第二电源模块（130）；第一电源模块（120）用于接收检测触发信号，并输出第一电源信号至熔断模块（210），以用于熔断模块（210）的状态检测；第二电源模块（130）用于接收熔断触发信号，并输出第二电源信号至熔断模块（210），以用于使熔断模块（210）处于断开状态。可以对一次性耗材端（20）进行区分识别，有效避免耗材的二次使用从而避免二次使用可能引发的安全风险，并且稳定性高、成本低。

Description

耗材管理系统、管理方法及血管钙化治疗设备
本申请要求于2021年11月8日提交的中国专利申请号为 202111316464.X、名称为“耗材管理系统、管理方法及血管钙化治疗设备”的优先权，其全部内容通过引用结合在本申请中。
技术领域
本申请涉及医疗器械技术领域，尤其涉及一种耗材管理系统、管理方法及血管钙化治疗设备。
 背景技术
血管狭窄是指羟磷灰石矿物质沉积于血管系统的病理过程，人体动静脉血管、冠脉、外周、颅内等血管由于脂质代谢不正常，血液中的脂质沉着在原本光滑的血管内膜，逐渐堆积成粥样的脂类斑块，随着时间推移，脂类斑块增多、钙化造成血管腔内狭窄，使血液流动受阻，导致下游血管和机体缺血，产生对应的临床表现。其中，30%~50%的血管狭窄会有钙化斑块，而且冠状动脉和外周动脉都有可能产生钙化病变，治疗难度极高。目前治疗钙化斑块的介入手术一般为“斑块旋切/旋磨术”，但这一手术方式难度系数极大。不仅如此，斑块旋切只能处理内膜血管的浅层钙化，而对中膜钙化、钙化结节或重度钙化则束手无策。
随着心血管介入技术的发展，针对血管钙化病变的技术日渐多样化。目前尝试使用一种由发生器、导管以及耗材球囊（球囊中设置有耗材电极）构成的冲击波治疗设备，即钙化治疗设备。通过导丝将球囊置于病变部位，然后使用超声波技术将钙化碎裂，达到治疗的目的。发生器和导管可连续多次用于患者治疗，但球囊作为一次性医疗耗材使用，耗材球囊直接与人体接触，耗材的安全也极其重要。
 技术问题
申请人发现，一般情况下，耗材的选择、使用及术后的失效处理都是操作者人为进行，耗材以及设备自身无对应的失效处理机制。目前，主要通过人为的方式进行耗材有效性管控，而人为管控不可避免的出现差错。人为管控时，若未正确区分耗材，将已使用的一次性耗材再次接入到设备上，在设备无法区分耗材的使用情况下，对患者进行治疗，将存在极大的安全隐患。一方面随着耗材的治疗使用，耗材存在损耗，过度使用耗材，其内部的可靠性难以保证，将对患者的安全及健康产生威胁。另一方面，二次使用时耗材的灭菌安全性难以保证，使用未完全灭菌的耗材将对患者健康产生严重威胁，从而不可避免的造成医疗安全事故。
 技术解决方案
针对上述技术问题，本申请提供一种耗材端管理系统、管理方法及血管钙化治疗设备，可以对一次性耗材端进行区分识别，因此能有效避免耗材的二次使用，从而避免二次使用可能引发的安全风险，并且稳定性高、成本低。
为实现上述目的，本发明实施例提供一种耗材端管理系统，作为其中一种实施方式，所述耗材端管理系统包括：控制电路和耗材电路，所述控制电路包括处理模块、第一电源模块以及第二电源模块，所述耗材电路包括熔断模块，所述耗材电路设置于耗材端，其中，
所述处理模块用于输出检测触发信号至所述第一电源模块，并在判定所述熔断模块的状态为导通状态时，输出熔断触发信号至所述第二电源模块；
所述第一电源模块用于接收所述检测触发信号，并输出第一电源信号至所述熔断模块，以用于所述熔断模块的状态检测；
所述第二电源模块用于接收所述熔断触发信号，并输出第二电源信号至所述熔断模块，以用于使所述熔断模块处于断开状态。
作为其中一种实施方式，所述处理模块在判定所述熔断模块的状态为导通状态且触发脉冲治疗时，输出所述熔断触发信号至所述第二电源模块，以控制所述第二电源模块输出第二电源信号至所述熔断模块，以用于使所述熔断模块处于断开状态。
作为其中一种实施方式，所述熔断模块包括熔断器和电阻，所述熔断器的第一端用于接收所述第一电源信号或所述第二电源信号，所述熔断器的第二端通过所述电阻接地；
所述处理模块与所述熔断器的第二端连接，用于获取监测信号，以根据所述监测信号判断所述熔断模块的状态。
作为其中一种实施方式，所述第一电源模块包括第一开关和电压源，所述第二电源模块包括第二开关和电流源；
所述第一开关在接收到所述检测触发信号时，导通所述电压源与所述熔断模块，以使得所述电压源输出所述第一电源信号至所述熔断模块；
所述第二开关在接收到所述熔断触发信号时，导通所述电流源与所述熔断模块，以使得所述电流源输出所述第二电源信号至所述熔断模块。
作为其中一种实施方式，所述控制电路还包括第三电源模块，所述耗材电路还包括连接模块，所述连接模块通过反馈信号线连接所述第三电源模块和所述处理模块；其中，
所述处理模块在通过所述连接模块接收到与所述第三电源模块输出的第三电源信号对应的反馈信号时，输出检测触发信号至所述第一电源模块。
基于同一发明构思，本发明提供一种耗材端管理方法，作为其中一种实施方式，所述方法包括：
输出检测触发信号至第一电源模块，以使得所述第一电源模块输出第一电源信号至耗材端中的熔断模块；
获取所述熔断模块的监测信号，以根据所述监测信号判断所述熔断模块的状态；
在判定所述熔断模块的状态为导通状态时，输出熔断触发信号至第二电源模块，以使得所述第二电源模块输出第二电源信号至所述熔断模块，从而使得所述熔断模块根据第二电源信号进行熔断。
作为其中一种实施方式，所述输出检测触发信号至第一电源模块，以使得所述第一电源模块输出第一电源信号至耗材端中的熔断模块的步骤包括：
在通过所述耗材端接收到与所述第三电源模块输出的所述第三电源信号对应的反馈信号时，输出所述检测触发信号至所述第一电源模块，以使得所述第一电源模块输出第一电源信号至耗材端中的熔断模块。
作为其中一种实施方式，所述在判定所述熔断模块的状态为导通状态时，输出熔断触发信号至第二电源模块，以使得所述第二电源模块输出第二电源信号至所述熔断模块，从而使得所述熔断模块根据第二电源信号进行熔断的步骤，包括：
在所述熔断模块的状态为导通状态时，监测脉冲治疗控制信号；
在获取到所述脉冲治疗控制信号时，输出熔断触发信号至第二电源模块，以使得所述第二电源模块输出第二电源信号至所述熔断模块，从而使得所述熔断模块根据第二电源信号进行熔断。
作为其中一种实施方式，所述在获取到所述脉冲治疗控制信号时，输出熔断触发信号至第二电源模块，以使得所述第二电源模块输出第二电源信号至所述熔断模块，从而使得所述熔断模块根据第二电源信号进行熔断的步骤之后，包括：
输出所述检测触发信号至所述第一电源模块，以使得所述第一电源模块输出所述第一电源信号至所述耗材端中的所述熔断模块；
获取所述熔断模块的监测信号，以根据所述监测信号判断所述熔断模块的状态；
在所述熔断模块处于断开状态时，将所述耗材端的剩余治疗次数设置为有效最大值；
在所述耗材端的剩余治疗次数大于0时，若接收到所述脉冲治疗控制信号，则触发脉冲治疗，并对所述耗材端的剩余治疗次数进行递减；
在所述耗材端的剩余治疗次数等于0时，若接收到所述脉冲治疗控制信号，则不触发脉冲治疗。
基于同一发明构思，本发明还提供一种血管钙化治疗设备，作为其中一种实施方式，所述血管钙化治疗设备包括设备端、连接器以及上述任一实施方式所述的耗材端，所述设备端通过所述连接器与所述耗材端连接，所述耗材端还包括耗材电极，所述设备端包括主电源模块、降压电路、升压电路以及上述任一实施方式所述的控制电路；其中，
所述主电源模块与所述升压电路连接，并通过所述降压电路与所述处理模块、所述第一电源模块以及所述第二电源模块连接，以进行供电；
所述处理模块与所述升压电路连接，用于控制所述升压电路输出脉冲信号；
所述升压电路与所述耗材电极连接，以形成高压放电回路释放所述脉冲信号。
 有益效果
综上，本发明实施例提供的耗材端管理系统包括控制电路和耗材电路，控制电路包括处理模块、第一电源模块以及第二电源模块，耗材电路包括熔断模块，耗材电路设置于耗材端，其中，处理模块用于输出检测触发信号至第一电源模块，并在判定熔断模块的状态为导通状态时，输出熔断触发信号至第二电源模块；第一电源模块用于接收检测触发信号，并输出第一电源信号至熔断模块，以用于熔断模块的状态检测；第二电源模块用于接收熔断触发信号，并输出第二电源信号至熔断模块，以用于使熔断模块处于断开状态。本发明可以对一次性耗材端进行区分识别，从而能有效避免耗材的二次使用，进而避免二次使用可能引发的安全风险，并且稳定性高、成本低。
本发明提供的耗材端管理方法及血管钙化治疗设备与本发明提供的耗材端管理系统属于同一发明构思，因此具有相同的有益效果。
 附图说明
此处所说明的附图用来提供对本发明的进一步理解，构成本申请的一部分，本发明的示意性实施例及其说明用于解释本发明，并不构成对本发明的不当限定。
图1为现有的血管钙化治疗设备的结构框图。
图2为本发明一实施例提供的耗材端管理系统的结构示意图。
图3为本发明一实施例提供的熔断模块的结构示意图。
图4为本发明一实施例提供的第一电源模块和第二电源模块的具体结构及其连接示意图。
图5为本发明另一实施例提供的耗材端管理系统的结构示意图。
图6为本发明一实施例提供的耗材端管理方法的流程示意图。
图7为本发明一实施例提供的血管钙化治疗设备的结构示意图。
图8为本发明一实施例提供的血管钙化治疗设备的工作流程示意图。
 本发明的最佳实施方式
为了使本领域的技术人员更好地理解本发明的技术方案，下面将结合本发明实施例中的附图，对本发明实施例中的技术方案进行清楚、完整的描述。显然，所描述的实施例仅仅是本发明一部分的实施例，而不是全部的实施例。本领域普通技术人员基于本发明的实施例，在没有创造性劳动前提下获得的所有其它实施例，都应当属于本发明的保护范围。
需要说明的是，本发明的说明书、权利要求书及上述附图中的术语“第一”、“第二”等是用于区别类似的对象，但不必用于描述特定的顺序或先后次序。应当理解这样使用的数据在适当情况下可以互换，以便这里描述的本发明的实施例能够以除了在这里图示或描述的那些以外的顺序实施。此外，术语“包括”和“具有”及其任何变形，意图在于覆盖不排他的包含，例如，包括了一系列步骤或单元的过程、方法、系统、产品或设备不必限于清楚地列出的那些步骤或单元，而是可以包括没有清楚地列出的或对于这些过程、方法、产品或设备固有的其他步骤或单元。
应该理解的是，虽然本申请实施例中的流程图中的各个步骤按照箭头的指示依次显示，但是这些步骤并不是必然按照箭头指示的顺序依次执行。除非本文中有明确的说明，这些步骤的执行并没有严格的顺序限制，其可以以其他的顺序执行。而且，图中的至少一部分步骤可以包括多个子步骤或者多个阶段，这些子步骤或者阶段并不必然是在同一时刻执行完成，而是可以在不同的时刻执行，其执行顺序也不必然是依次进行，而是可以与其他步骤或者其他步骤的子步骤或者阶段的至少一部分轮流或者交替地执行。
除非另有定义，本文所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本文在本发明的说明书中所使用的术语只是为了描述具体的实施例的目的，不是旨在于限制本发明。
在进行具体实施例描述前，需要说明的是，本申请可以用于各种一次性的耗材管理，可以准确区分识别新耗材和旧耗材，例如用于治疗血管钙化的冲击波治疗设备的耗材管理。请参考图1，图1为现有的血管钙化治疗设备的结构框图。如图1所示，现有的血管钙化治疗设备包括设备端10、耗材端20以及连接器30，设备端10通过连接器30与耗材端20连接。治疗时耗材端通20过导引导丝输送到待治疗的血管部位，设备端10产生高压脉冲通过连接器30输送到耗材端20的电极上，通过耗材电极产生冲击波，将钙化组织碎裂。
对于上述使用无法重复使用的耗材端的设备，无法对耗材端进行区分识别，会出现耗材端重复使用的问题。而本申请提供的耗材端管理系统可以设置在此种设备上进行耗材端管理，对一次性耗材端进行区分识别，有效避免耗材的二次使用从而避免二次使用可能引发的安全风险，并且稳定性高、成本低。
请参考图2，图2为本发明一实施例提供的耗材端管理系统的结构示意图。如图2所示，耗材端管理系统包括：控制电路100和耗材电路200，控制电路100包括处理模块110、第一电源模块120以及第二电源模块130，耗材电路200包括熔断模块210，耗材电路200设置于耗材端，其中，
处理模块110用于输出检测触发信号至第一电源模块120，并在判定熔断模块210的状态为导通状态时，输出熔断触发信号至第二电源模块130；
第一电源模块120用于接收检测触发信号，并输出第一电源信号至熔断模块210，以用于熔断模块210的状态检测；
第二电源模块130用于接收熔断触发信号，并输出第二电源信号至熔断模块210，以用于使熔断模块210处于断开状态。
具体地，控制电路100与耗材电路200可以通过连接器连接，熔断模块210设置在耗材端，处理模块110、第一电源模块120以及第二电源模块130可以设置在设备端，处理模块110可以是微控制器。当耗材端与设备端连接，则控制电路100与耗材电路200连接，以及耗材端的耗材与设备端相应的装置连接（例如血管钙化治疗设备中耗材端的耗材电极与设备端的升压电路的输出端连接），处理模块110输出检测触发信号至第一电源模块120，第一电源模块120输出接收到检测触发信号后输出第一电源信号至熔断模块210，以用于熔断模块210的状态检测，即判断熔断模块210是否处于发生熔断状态。当处理模块110判定熔断模块210的状态为导通状态，即还没有发生熔断时，此时也即耗材端为新耗材端，处理模块110然后通过输出熔断触发信号至第二电源模块130，第二电源模块130在接收到熔断触发信号后输出第二电源信号至熔断模块210，以用于使熔断模块210处于断开状态，即使熔断模块210发生熔断。当处理模块110在耗材端接入后尚未进行熔断处理时判定熔断模块210的状态为断开状态，即已经发生熔断时，则判定该耗材为旧耗材，无需发送熔断触发信号。
需要说明的是，在处理模块110判定熔断模块210的状态后，处理模块110停止输出检测触发信号。
在一实施方式中，处理模块110在判定熔断模块210的状态为导通状态且触发脉冲治疗时，控制第二电源模块130输出第二电源信号至熔断模块210，以用于使熔断模块210处于断开状态。
具体地，为了避免将已经接入但是未进行治疗使用的新的耗材端误判为旧耗材，而将熔断模块210熔断的问题发生，例如血管钙化治疗设备中，耗材端接入设备端，但是设备端未发送高压脉冲至耗材端的耗材电极，也即耗材端实质上未进行过治疗使用，却将耗材端误判为旧耗材而将熔断模块210熔断的问题发生，在本实施方式中，处理模块110在判定熔断模块210的状态为导通状态，且触发脉冲治疗时（即处理模块110检测到触发过脉冲治疗，或者检测到发送过脉冲治疗信号时），输出熔断触发信号至第二电源模块，以控制第二电源模块130输出第二电源信号至熔断模块210，以用于使熔断模块210处于断开状态。
在一实施方式中，处理模块110在输出熔断触发信号至第二电源模块130，以使得第二电源模块130输出第二电源信号至熔断模块210，以用于使熔断模块210处于断开状态之后，再次输出检测触发信号至第一电源模块120，以使得第一电源模块120输出第一电源信号至熔断模块210，以用于判断熔断模块210是否处于断开状态。
 本发明的实施方式
请参考图3，图3为本发明一实施例提供的熔断模块的结构示意图。如图3所示，在一实施方式中，熔断模块210包括熔断器FU和电阻R，熔断器FU的第一端用于接收第一电源信号或第二电源信号，熔断器FU的第二端通过电阻R接地。
其中，处理模块110与熔断器FU的第二端连接，用于获取监测信号，以用于判断熔断模块210的状态。
具体地，当第一电源信号输出至熔断模块210时，此时若耗材端为新的耗材端，第一电源信号经熔断器FU以及电阻R到电源地，第一电源信号的电压信号幅值较低，流过熔断器FU的电流不能将熔断器FU熔断，此时处理模块110获取的监测信号为高电平，处理模块110检测到高电平信号后认为是新耗材。若耗材端为使用过的耗材端，熔断模块210中的熔断器FU已熔断，电流无法流过熔断器FU，此时处理模块110获取的监测信号为低电平。因此可以通过监测信号的高低电平的差异，区分耗材端的使用状态。
在一实施方式中，在耗材端的检测完成后，处理模块110不再进行监测信号的检测，同时，处理模块110控制第一电源模块120停止输出。
请参考图4，图4为本发明一实施例提供的第一电源模块和第二电源模块的具体结构及其连接示意图。如图4所示，在一实施方式中，第一电源模块120包括第一开关K1和电压源Us，第二电源模块130包括第二开关K2和电流源Is。
其中，第一开关K1在接收到检测触发信号时，导通电压源Us与熔断模块210，以使得电压源Us输出第一电源信号至熔断模块210。第二开关K2在接收到熔断触发信号时，导通电流源Is与熔断模块210，以使得电流源Is输出第二电源信号至熔断模块210。
请参考图5，图5为本发明另一实施例提供的耗材端管理系统的结构示意图。如图5所示，在一实施方式中，控制电路100还包括第三电源模块140，耗材电路200还包括连接模块220，连接模块220用于连接第三电源模块140和处理模块110。
其中，处理模块110在通过连接模块220接收到与第三电源模块140输出的第三电源信号对应的反馈信号时，输出检测触发信号至第一电源模块120。
具体地，连接模块220，例如可以包括一导线，用于连接第三电源模块140的输出端与处理模块110的反馈信号引脚，在设置在耗材端的连接模块220连接第三电源模块140和处理模块110时，处理模块110的引脚接收到与第三电源模块140输出的第三电源信号对应的反馈信号，处理模块110根据反馈信号判断耗材端已接入设备端。例如，耗材端未接入时，反馈信号为低电平信号，在耗材端接入后，反馈信号将为高电平信号。同样耗材端断开与设备端的连接后，反馈信号引脚将变为低电平。设备端判断耗材端接入后开始检测耗材端中熔断模块210的状态，区分接入的耗材端是新耗材端还是已使用过的耗材端。
在一实施方式中，处理模块110还用于根据脉冲治疗控制信号，对耗材端的剩余治疗次数进行递减。
具体地，处理模块110输出熔断触发信号至第二电源模块，以控制熔断模块熔断后，或在确认熔断模块210有效地熔断了后，将剩余治疗次数设置为有效最大值。设备端可按照显示的剩余治疗次数进行脉冲治疗。随着使用者的每次脉冲治疗，即处理模块110在接收到脉冲治疗控制信号时，将剩余治疗次数减一，直至剩余治疗次数递减为零。
在一实施方式中，控制电路100还包括备用电源，备用电源用于在处理模块110处于低功耗状态时为处理模块110供电。
具体地，在为处理模块110供电的设备端主电源关闭后，处理模块110触发低功耗状态，备份电池为处理模块110供电，处理模块110未彻底断电，仍可记忆耗材端的剩余治疗次数，以便耗材端再次使用时，处理模块110可根据剩余治疗次数，继续进行脉冲治疗。
在一实施方式中，控制电路100还包括报警模块，处理模块110与报警模块连接，用于在耗材端的剩余治疗次数为0时，控制报警模块进行告警提示。
具体地，报警模块可以为蜂鸣器和/或LED灯等。
综上，本发明实施例提供的耗材端管理系统，可以对一次性耗材端进行区分识别，从而能有效避免耗材的二次使用，进而能避免二次使用可能引发的安全风险，还能对耗材端的使用进行有效的安全管控，并且稳定性高、成本低。
基于同一发明构思，本发明实施例还提供一种耗材端管理方法。请参考图6，图6为本发明一实施例提供的耗材端管理方法的流程示意图。如图6所示，方法包括：
S10，输出检测触发信号至第一电源模块，以使得第一电源模块输出第一电源信号至耗材端中的熔断模块。
在一实施方式中，步骤S10，输出检测触发信号至第一电源模块，以使得第一电源模块输出第一电源信号至耗材端中的熔断模块，包括：
在通过耗材端接收到与第三电源模块输出的第三电源信号对应的反馈信号时，输出检测触发信号至第一电源模块，以使得第一电源模块输出第一电源信号至耗材端中的熔断模块。
S20，获取熔断模块的监测信号，以根据监测信号判断熔断模块的状态。
具体地，熔断模块的状态包括导通状态和断开状态，导通状态代表耗材端为新耗材，断开状态代表耗材端为使用过的耗材。
S30，在判定熔断模块的状态为导通状态时，输出熔断触发信号至第二电源模块，以使得第二电源模块输出第二电源信号至熔断模块，从而使得熔断模块根据第二电源信号进行熔断。
在一实施方式中，步骤S30，在判定熔断模块的状态为导通状态时，输出熔断触发信号至第二电源模块，以使得第二电源模块输出第二电源信号至熔断模块，从而使得熔断模块根据第二电源信号进行熔断，包括：
在判定熔断模块的状态为导通状态时，监测脉冲治疗控制信号；
在获取到脉冲治疗控制信号时，输出熔断触发信号至第二电源模块，以使得第二电源模块输出第二电源信号至熔断模块，从而使得熔断模块根据第二电源信号进行熔断。
在一实施方式中，在获取到脉冲治疗控制信号时，输出熔断触发信号至第二电源模块，以使得第二电源模块输出第二电源信号至熔断模块，从而使得熔断模块根据第二电源信号进行熔断的步骤之后，包括：
输出检测触发信号至第一电源模块，以使得第一电源模块输出第一电源信号至耗材端中的熔断模块；
获取熔断模块的监测信号，以根据监测信号判断熔断模块的状态；
在判定熔断模块处于断开状态时，将耗材端的剩余治疗次数设置为有效最大值；
在接收到脉冲治疗控制信号时，判断耗材端的剩余治疗次数是否大于0；
在耗材端的剩余治疗次数大于0时，则触发脉冲治疗，并对耗材端的剩余治疗次数进行递减；
在耗材端的剩余治疗次数等于0时，则不触发脉冲治疗。
需要说明的是，耗材端的剩余治疗次数设置为有效最大值，指在耗材端的默认最大值的基础上减去1。
在一实施方式中，耗材端管理方法还包括：
在判定熔断模块的状态为断开状态时，监测脉冲治疗控制信号；
在接收到脉冲治疗控制信号时，判断耗材端的剩余治疗次数是否大于0；
在耗材端的剩余治疗次数大于0时，则触发脉冲治疗，并对耗材端的剩余治疗次数进行递减；
在耗材端的剩余治疗次数等于0时，则不触发脉冲治疗。
在一实施方式中，在耗材端的剩余治疗次数等于0时，则不触发脉冲治疗的步骤之后，还包括：
进行告警提示。
需要说明的是，本方法实施例未进行说明或详细说明的地方请参考前述实施例描述，此处不再进行赘述。
综上，本发明实施例提供的耗材端管理方法，可以对一次性耗材端进行区分识别，有效避免耗材的二次使用从而避免二次使用可能引发的安全风险，还能对耗材端的使用进行有效的安全管控，并且稳定性高、成本低。
基于同一发明构思，本发明实施例还提供一种耗材端管理方法。请参考图7，图7为本发明一实施例提供的血管钙化治疗设备的结构示意图。如图7所示，该设备包括：设备端10a、耗材端20a以及连接器30a，设备端通过连接器与耗材端连接，耗材端20a包括耗材电极230以及上述任一实施方式所述的耗材电路200，设备端10a包括主电源模块150、降压电路160、升压电路170以及上述任一实施方式的控制电路100；其中，
主电源模块150与升压电路170连接，并通过降压电路160与处理模块110、第一电源模块120以及第二电源模块130连接，以进行供电；
处理模块110与升压电路170连接，用于控制升压电路170输出脉冲信号；
升压电路170与耗材电极230连接，以形成高压放电回路释放脉冲信号。
在一实施方式中，主电源模块150通过降压电路160与第三电源模块140连接，以进行供电。
为了更加清楚的描述本发明的技术方案，下面对图7所示的血管钙化治疗设备的工作流程进行详细说明。请结合参考图8，图8为本发明一实施例提供的血管钙化治疗设备的工作流程示意图。如图8所示，血管钙化治疗设备的工作流程包括如下步骤：
S110：设备端监测反馈信号是否为高电平；
在反馈信号为低电平时，返回步骤S110；
在反馈信号为高电平时，进入步骤S111：设备端输出第一电源信号至耗材端，并接收监测信号；
S112：根据监测信号判断耗材端是否为新耗材；
在判定耗材端为旧耗材时，进入步骤S117
在判断耗材端为新耗材时，进入步骤S113：设备端是否接收到脉冲治疗控制信号；
在设备端没有接收到脉冲治疗控制信号时返回步骤S113；
在设备端接收到脉冲治疗控制信号时进入步骤S114：设备端输出第二电源信号至耗材端，以使耗材端进行熔断。
步骤S115：检测耗材端是否有效熔断；
在耗材端没有有效熔断时，返回步骤S114；
在耗材端有效熔断时，进入步骤S116：设备端将耗材端的剩余治疗次数设置为有效最大值；
步骤S117：判断是否接收到脉冲治疗控制信号；
在未接收到脉冲治疗控制信号时，返回步骤S117；
在接收到脉冲治疗控制信号时，进入步骤S118：判断耗材端的剩余治疗次数是否大于0；
在耗材端的剩余治疗次数大于0时，进入步骤S119：触发脉冲治疗，并对耗材端的剩余治疗次数减1；
在耗材端的剩余治疗次数不大于0时，进入步骤S120：不触发脉冲治疗，并发送生命周期结束的告警提示。
需要说明的是，本方法实施例未进行说明或详细说明的地方请参考前述实施例描述，此处不再进行赘述。
 工业实用性
综上，本发明实施例提供的血管钙化治疗设备，可以对一次性耗材端进行区分识别，因此能有效避免耗材的二次使用，从而避免二次使用可能引发的安全风险，还能对耗材端的使用进行有效的安全管控，并且稳定性高、成本低。
以上所述，仅是本发明的较佳实施例而已，并非对本发明作任何形式上的限制，虽然本发明已以较佳实施例揭露如上，然而并非用以限定发明，任何熟悉本专业的技术人员，在不脱离发明技术方案范围内，当可利用上述揭示的技术内容作出些许更动或修饰为等同变化的等效实施例，但凡是未脱离发明技术方案内容，依据发明的技术实质对以上实施例所作的任何简单修改、等同变化与修饰，均仍属于本发明技术方案的范围内。

Claims (10)

  1. 一种耗材端管理系统，其特征在于，包括控制电路和耗材电路，所述控制电路包括处理模块、第一电源模块以及第二电源模块，所述耗材电路包括熔断模块，所述耗材电路设置于耗材端，其中，
    所述处理模块用于输出检测触发信号至所述第一电源模块，并在判定所述熔断模块的状态为导通状态时，输出熔断触发信号至所述第二电源模块；
    所述第一电源模块用于接收所述检测触发信号，并输出第一电源信号至所述熔断模块，以用于所述熔断模块的状态检测；
    所述第二电源模块用于接收所述熔断触发信号，并输出第二电源信号至所述熔断模块，以用于使所述熔断模块处于断开状态。
  2. 根据权利要求1所述的耗材端管理系统，其特征在于，所述处理模块在判定所述熔断模块的状态为导通状态且触发脉冲治疗时，输出所述熔断触发信号至所述第二电源模块，以控制所述第二电源模块输出第二电源信号至所述熔断模块，以用于使所述熔断模块处于断开状态。
  3. 根据权利要求1所述的耗材端管理系统，其特征在于，所述熔断模块包括熔断器和电阻，所述熔断器的第一端用于接收所述第一电源信号或所述第二电源信号，所述熔断器的第二端通过所述电阻接地；
    所述处理模块与所述熔断器的第二端连接，用于获取监测信号，以根据所述监测信号判断所述熔断模块的状态。
  4. 根据权利要求1所述的耗材端管理系统，其特征在于，所述第一电源模块包括第一开关和电压源，所述第二电源模块包括第二开关和电流源；
    所述第一开关在接收到所述检测触发信号时，导通所述电压源与所述熔断模块，以使得所述电压源输出所述第一电源信号至所述熔断模块；
    所述第二开关在接收到所述熔断触发信号时，导通所述电流源与所述熔断模块，以使得所述电流源输出所述第二电源信号至所述熔断模块。
  5. 根据权利要求1所述的耗材端管理系统，其特征在于，所述控制电路还包括第三电源模块，所述耗材电路还包括连接模块，所述连接模块通过反馈信号线连接所述第三电源模块和所述处理模块；其中，
    所述处理模块在通过所述连接模块接收到与所述第三电源模块输出的第三电源信号对应的反馈信号时，输出检测触发信号至所述第一电源模块。
  6. 一种耗材端管理方法，其特征在于，所述方法包括：
    输出检测触发信号至第一电源模块，以使得所述第一电源模块输出第一电源信号至耗材端中的熔断模块；
    获取所述熔断模块的监测信号，以根据所述监测信号判断所述熔断模块的状态；
    在判定所述熔断模块的状态为导通状态时，输出熔断触发信号至第二电源模块，以使得所述第二电源模块输出第二电源信号至所述熔断模块，从而使得所述熔断模块根据第二电源信号进行熔断。
  7. 根据权利要求6所述的耗材端管理方法，其特征在于，所述输出检测触发信号至第一电源模块，以使得所述第一电源模块输出第一电源信号至耗材端中的熔断模块的步骤包括：
    在通过所述耗材端接收到与所述第三电源模块输出的所述第三电源信号对应的反馈信号时，输出所述检测触发信号至所述第一电源模块，以使得所述第一电源模块输出第一电源信号至耗材端中的熔断模块。
  8. 根据权利要求6或7所述的耗材端管理方法，其特征在于，所述在判定所述熔断模块的状态为导通状态时，输出熔断触发信号至第二电源模块，以使得所述第二电源模块输出第二电源信号至所述熔断模块，从而使得所述熔断模块根据第二电源信号进行熔断的步骤，包括：
    在判定所述熔断模块的状态为导通状态时，监测脉冲治疗控制信号；
    在获取到所述脉冲治疗控制信号时，输出熔断触发信号至第二电源模块，以使得所述第二电源模块输出第二电源信号至所述熔断模块，从而使得所述熔断模块根据第二电源信号进行熔断。
  9. 根据权利要求8所述的耗材端管理方法，其特征在于，所述在获取到所述脉冲治疗控制信号时，输出熔断触发信号至第二电源模块，以使得所述第二电源模块输出第二电源信号至所述熔断模块，从而使得所述熔断模块根据第二电源信号进行熔断的步骤之后，包括：
    输出所述检测触发信号至所述第一电源模块，以使得所述第一电源模块输出所述第一电源信号至所述耗材端中的所述熔断模块；
    获取所述熔断模块的监测信号，以根据所述监测信号判断所述熔断模块的状态；
    在判定所述熔断模块处于断开状态时，将所述耗材端的剩余治疗次数设置为有效最大值；
    在所述耗材端的剩余治疗次数大于0时，若接收到所述脉冲治疗控制信号，则触发脉冲治疗，并对所述耗材端的剩余治疗次数进行递减；
    在所述耗材端的剩余治疗次数等于0时，若接收到所述脉冲治疗控制信号，则不触发脉冲治疗。
  10. 一种血管钙化治疗设备，其特征在于，包括设备端、连接器以及如权利要求1-5任一项所述的耗材端，所述设备端通过所述连接器与所述耗材端连接，所述耗材端还包括耗材电极，所述设备端包括主电源模块、降压电路、升压电路以及如权利要求1-5任一项所述的控制电路；其中，
    所述主电源模块与所述升压电路连接，并通过所述降压电路与所述处理模块、所述第一电源模块以及所述第二电源模块连接，以进行供电；
    所述处理模块与所述升压电路连接，用于控制所述升压电路输出脉冲信号；
    所述升压电路与所述耗材电极连接，以形成高压放电回路释放所述脉冲信号。
PCT/CN2022/130739 2021-11-08 2022-11-08 耗材管理系统、管理方法及血管钙化治疗设备 Ceased WO2023078465A1 (zh)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP22889486.1A EP4397256A4 (en) 2021-11-08 2022-11-08 CONSUMABLES MANAGEMENT SYSTEM AND MANAGEMENT METHOD AND VASCULAR CALCIFICATION TREATMENT DEVICE
JP2024526756A JP7652475B2 (ja) 2021-11-08 2022-11-08 消耗品端の管理システム、管理方法及び血管石灰化治療装置
US18/703,373 US20250235225A1 (en) 2021-11-08 2022-11-08 Consumable management system and management method and vascular calcification treatment device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111316464.XA CN114010269A (zh) 2021-11-08 2021-11-08 耗材管理系统、管理方法及血管钙化治疗设备
CN202111316464.X 2021-11-08

Publications (1)

Publication Number Publication Date
WO2023078465A1 true WO2023078465A1 (zh) 2023-05-11

Family

ID=80062581

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/130739 Ceased WO2023078465A1 (zh) 2021-11-08 2022-11-08 耗材管理系统、管理方法及血管钙化治疗设备

Country Status (5)

Country Link
US (1) US20250235225A1 (zh)
EP (1) EP4397256A4 (zh)
JP (1) JP7652475B2 (zh)
CN (1) CN114010269A (zh)
WO (1) WO2023078465A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114010269A (zh) * 2021-11-08 2022-02-08 江苏朴芃医疗科技有限公司 耗材管理系统、管理方法及血管钙化治疗设备
CN114699061B (zh) * 2022-03-21 2025-12-16 江苏朴芃医疗科技有限公司 放电检测电路、方法、高压发生器及血管钙化治疗设备
CN115389852A (zh) * 2022-09-23 2022-11-25 苏州中荟医疗科技有限公司 识别导管的高压脉冲发生器、导管识别装置及冲击波装置

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010048623A (ja) * 2008-08-20 2010-03-04 Tanita Corp バイオセンサカートリッジの再利用を防止する、バイオセンサカートリッジを使用する生化学測定器
CN103765106A (zh) * 2011-05-20 2014-04-30 博世株式会社 火花塞、火花塞新旧判断方法及火花塞驱动控制装置
CN107239060A (zh) * 2017-07-21 2017-10-10 杭州得道医疗设备科技有限公司 一种医用手术电极使用次数控制系统及方法
CN109061377A (zh) * 2018-06-22 2018-12-21 珠海美佳音科技有限公司 打印机耗材保险丝仿真芯片
CN111031823A (zh) * 2017-09-08 2020-04-17 菲利普莫里斯生产公司 消耗品标识
CN212700035U (zh) * 2020-08-25 2021-03-16 深圳市赛禾医疗技术有限公司 压力波球囊导管、用于血管成形术的电源主机及治疗装置
CN114010269A (zh) * 2021-11-08 2022-02-08 江苏朴芃医疗科技有限公司 耗材管理系统、管理方法及血管钙化治疗设备

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62148659A (ja) * 1984-12-05 1987-07-02 オリンパス光学工業株式会社 放電結石破壊装置
DE3543096A1 (de) * 1984-12-05 1986-06-05 Olympus Optical Co., Ltd., Tokio/Tokyo Vorrichtung zur zertruemmerung von steinen, wie nieren- und gallensteinen oder dergleichen
US5573533A (en) * 1992-04-10 1996-11-12 Medtronic Cardiorhythm Method and system for radiofrequency ablation of cardiac tissue
US6270460B1 (en) * 1999-06-24 2001-08-07 Acuson Corporation Apparatus and method to limit the life span of a diagnostic medical ultrasound probe
US7176030B2 (en) * 2002-06-17 2007-02-13 O.R. Solutions, Inc. Method and apparatus for ensuring sterility of disposable medical items used with medical equipment
NO20052590D0 (no) * 2005-05-27 2005-05-27 Thales Norway As Tilkoblings- og frakoblingsanordning og et baerbart system som benytter anordningen.
KR100660899B1 (ko) * 2005-12-15 2006-12-26 삼성전자주식회사 누설 전류 패스를 제거할 수 있는 퓨즈 회로
US20090065565A1 (en) * 2007-09-12 2009-03-12 Vascular Technologies, Inc. System, method and apparatus for preventing reuse of medical instruments
TW201249044A (en) * 2011-05-20 2012-12-01 Hon Hai Prec Ind Co Ltd Power protecting circuit
CN103311876B (zh) * 2013-06-20 2015-09-30 华为技术有限公司 一种供电熔丝告警电路及告警装置
DE102016210058A1 (de) * 2016-06-08 2017-12-14 Robert Bosch Gmbh Stromverteiler und Sicherungssystem für ein Fahrzeug
JP6493314B2 (ja) * 2016-06-15 2019-04-03 トヨタ自動車株式会社 電気自動車
JP6497754B2 (ja) * 2017-02-10 2019-04-10 Ｎｅｃプラットフォームズ株式会社 電力供給システム、回路基板及び電力供給システムの制御方法
CN112022338B (zh) * 2019-06-04 2022-07-01 赛诺微医疗科技（浙江）有限公司 电穿孔消融电极针及使用其的治疗系统
JP7404999B2 (ja) * 2020-05-14 2023-12-26 株式会社オートネットワーク技術研究所 給電制御装置、溶断方法及びコンピュータプログラム
TWI749776B (zh) * 2020-09-21 2021-12-11 致茂電子股份有限公司 電壓隔離電路
CN112773421A (zh) * 2021-01-28 2021-05-11 中国医学科学院北京协和医院 一种微创手术耗材计数方法及运用该方法的装置
CN113576598A (zh) * 2021-07-27 2021-11-02 江苏朴芃医疗科技有限公司 电极耗材交互方法、钙化斑块医疗设备及可读存储介质
DE112023005250T5 (de) * 2022-12-21 2025-10-02 Yazaki Corporation Leistungsquellen-Steuersystem

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010048623A (ja) * 2008-08-20 2010-03-04 Tanita Corp バイオセンサカートリッジの再利用を防止する、バイオセンサカートリッジを使用する生化学測定器
CN103765106A (zh) * 2011-05-20 2014-04-30 博世株式会社 火花塞、火花塞新旧判断方法及火花塞驱动控制装置
CN107239060A (zh) * 2017-07-21 2017-10-10 杭州得道医疗设备科技有限公司 一种医用手术电极使用次数控制系统及方法
CN111031823A (zh) * 2017-09-08 2020-04-17 菲利普莫里斯生产公司 消耗品标识
CN109061377A (zh) * 2018-06-22 2018-12-21 珠海美佳音科技有限公司 打印机耗材保险丝仿真芯片
CN212700035U (zh) * 2020-08-25 2021-03-16 深圳市赛禾医疗技术有限公司 压力波球囊导管、用于血管成形术的电源主机及治疗装置
CN114010269A (zh) * 2021-11-08 2022-02-08 江苏朴芃医疗科技有限公司 耗材管理系统、管理方法及血管钙化治疗设备

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP4397256A4

Also Published As

Publication number Publication date
CN114010269A (zh) 2022-02-08
EP4397256A1 (en) 2024-07-10
JP2024538348A (ja) 2024-10-18
EP4397256A4 (en) 2025-09-17
US20250235225A1 (en) 2025-07-24
JP7652475B2 (ja) 2025-03-27

Similar Documents

Publication Publication Date Title
WO2023078465A1 (zh) 耗材管理系统、管理方法及血管钙化治疗设备
US11547474B2 (en) Control methods and devices for energy delivery
CN106456270B (zh) 医疗装置
US9265941B2 (en) Lead set for nerve stimulator and method of operation thereof
EP2024006B1 (en) Apparatus for stimulating a nerve of a patient
US9757578B2 (en) Electrocardiogram monitoring
JP4245923B2 (ja) ４接触部識別細動除去装置電極システム
CN110234289A (zh) 确保脉冲场消融发生器系统电气安全的方法
JP2004528076A (ja) 除細動ショックまでの遅延が最小化された双方向心肺蘇生実行方法
CN1713858A (zh) 电外科发生器及用来检测故障的方法
JP2000107189A (ja) ディスポーザブル医療器具及びこれを組み込んだ医療装置
US6694187B1 (en) External defibrillator instruction system and method
US9433459B2 (en) Deposit ablation within and external to circulatory systems
US9393402B2 (en) Electrode tray with integrated connector and storage for wires
US12220165B2 (en) Control methods and devices for energy delivery
WO2014055359A1 (en) Deposit ablation within and external to circulatory systems
JP2016067574A (ja) 神経刺激装置

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22889486

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2022889486

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 18703373

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2024526756

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2022889486

Country of ref document: EP

Effective date: 20240402

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 18703373

Country of ref document: US